📣 VC round data is live. Check it out!
- Public Comps
- Corteva
Corteva Valuation Multiples
Discover Corteva's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like BASF, Archer-Daniels-Midland, Archer-Daniels-Midland, Nutrien and more.
Corteva Overview
About Corteva
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in late 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.
Founded
2018
HQ

Employees
21.5K
Website
Sectors
Financials (LTM)
EV
$53B
Valuation Multiples
Start free trialCorteva Financials
Corteva reported last 12-month revenue of $18B and EBITDA of $4B.
In the same LTM period, Corteva generated $8B in gross profit, $4B in EBITDA, and $2B in net income.
Revenue (LTM)
Corteva P&L
In the most recent fiscal year, Corteva reported revenue of $17B and EBITDA of $4B.
Corteva is profitable as of last fiscal year, with gross margin of 47%, EBITDA margin of 22%, and net margin of 13%.
Financial data powered by Morningstar, Inc.
Corteva Stock Performance
Corteva has current market cap of $52B, and enterprise value of $53B.
Market Cap Evolution
Corteva's stock price is $77.68.
Corteva share price decreased by 0.8% in the last 30 days, and increased by 4.2% in the last year.
Corteva has an EPS (earnings per share) of $3.40.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $53B | $52B | -0.8% | -0.8% | -7.2% | 4.2% | $3.40 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCorteva Valuation Multiples
Corteva trades at 3.0x EV/Revenue multiple, and 13.4x EV/EBITDA.
EV / Revenue (LTM)
Corteva Financial Valuation Multiples
As of June 2, 2026, Corteva has market cap of $52B and EV of $53B.
Corteva has a P/E ratio of 21.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Corteva Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Corteva Margins & Growth Rates
Corteva grew revenue by 5% and EBITDA by 9% in the last fiscal year.
In the most recent fiscal year, Corteva reported gross margin of 47%, EBITDA margin of 22%, and net margin of 13%.
Corteva Margins
Corteva Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Corteva Operational KPIs
Corteva's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.3M for the same period.
Corteva's Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Corteva's Rule of X is 36% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Corteva Competitors
Corteva competitors include BASF, Archer-Daniels-Midland, Archer-Daniels-Midland, Nutrien, Novonesis, Bunge, Qinghai Salt Lake Industry, Industries Qatar and Wilmar International.
Most Corteva public comparables operate across Agriculture.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.1x | 1.1x | 8.6x | 9.5x | |||
| 0.6x | 0.6x | 13.4x | 12.4x | |||
| 0.6x | - | 15.9x | - | |||
| 1.7x | 1.7x | 7.6x | 7.4x | |||
| 6.2x | 6.1x | 16.8x | 16.4x | |||
| 0.6x | 0.5x | 14.9x | 12.6x | |||
| 8.7x | 6.6x | 16.3x | 11.8x | |||
This data is available for Pro users. Sign up to see all Corteva competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Corteva
Corteva has acquired 2 companies to date.
Last acquisition by Corteva was on March 2nd 2023. Corteva acquired Symborg for $370M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Corteva
| Description | Symborg is a Murcia, Spain-headquartered biotechnology firm specializing in mycorrhizal inoculants for agriculture. Founded in 2012, it supplies biological products like Biko and MycoUp to enhance crop yields in over 40 countries across Europe, the Americas, and Asia, with subsidiaries in the United States and Brazil. | The Stoller Group is a Houston-headquartered provider of plant growth regulators and biostimulants enhancing crop yields for farmers globally. Operating in 40 countries across the Americas, Europe, Asia, and Africa, its products like Epic and Folistim target soybeans, corn, and sugarcane to improve stress tolerance and productivity. |
| HQ Country | ||
| HQ City | Murcia | Houston, TX |
| Deal Date | 2 Mar 2023 | 30 Nov 2022 |
| Valuation | $370M | $1B |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Corteva acquisitions and their M&A valuation multiples. Start Free Trial | ||
Investments by Corteva
Corteva has invested in 4 companies to date.
Latest investment by Corteva was on February 13th 2025. Corteva invested in IBI-Ag in their $6M Series A round (EV/Revenue multiple available to Pro users).
Latest Investments by Corteva
| Description | IBI-Ag is a Rehovot-based biotechnology firm developing bioinsecticides using RNA interference technology. Founded in 2015, the company targets crop pests like aphids and whiteflies with environmentally safe solutions produced via fermentation. Its lead product, IBI-100, controls tomato pests in greenhouses, reducing chemical use by 90 percent. IBI-Ag collaborates with agrochemical giants like BASF and serves farmers in Israel, Europe, and North America, emphasizing cost-effective, selective insect control. | Micropep Technologies is a Toulouse-based biotechnology firm founded in 2016 that develops non-GMO bioherbicides and biostimulants from plant micropeptides. These molecules regulate gene expression to control germination, flowering, growth, and weed development without altering DNA. The company advances four key programs targeting agricultural challenges in crop protection and yield improvement. Micropep Technologies partners with agrotech firms in Europe to commercialize peptide-based products for sustainable farming. | Pairwise Plants is a gene-editing company developing improved fruits and vegetables using base editing technologies licensed from Harvard and Massachusetts General Hospital. Durham, North Carolina-headquartered and founded in 2018, it targets leafy greens, berries, and stone fruits, with commercial products like seedless blackberries launched in 2024 through partnerships with retailer Pilot Company. Pairwise employs 150 scientists and operates greenhouses in the Southeast U.S., holding over 100 patents for traits enhancing flavor, texture, and shelf life. | Solasta Bio is a Denmark-based developer of bio-based crop protection products that offer environmentally sustainable alternatives to chemical pesticides. The company produces biological fungicides and insecticides targeting diseases in fruits, vegetables, and cereals, with flagship products like Beauveria bassiana formulations achieving EU registration. Founded in 2020, Solasta serves European growers through distributors in over 10 countries, emphasizing low-residue solutions compliant with organic farming standards. |
| HQ Country | ||||
| HQ City | Ness Ziona | Toulouse | Durham, NC | Glasgow |
| Deal Date | 13 Feb 2025 | 26 Sep 2024 | 17 Sep 2024 | 11 Sep 2024 |
| Round | Series A | Series B | Series C | Series A |
| Raised | $6M | $11M | $40M | $14M |
| Investors | Consensus Business Group; Corteva; Iron Nation; Trendlines Group | Corteva; Sparkfood | Aliment Capital; Corteva; Deerfield Management; Leaps by Bayer | Cavallo Ventures; Corteva; FMC Ventures; Forbion Capital Partners; Rubio Impact Ventures; Scottish Enterprise; SIS Ventures; UK Innovation & Science Seed Fund; University of Glasgow |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed |
| EV/Revenue | ||||
| EV/EBITDA | ||||
This data is available for Pro users. Sign up to see all Corteva investments and their VC round multiples. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Corteva
| When was Corteva founded? | Corteva was founded in 2018. |
| Where is Corteva headquartered? | Corteva is headquartered in United States. |
| How many employees does Corteva have? | As of today, Corteva has over 21K employees. |
| Who is the CEO of Corteva? | Corteva's CEO is Charles Victor Magro. |
| Is Corteva publicly listed? | Yes, Corteva is a public company listed on NYSE. |
| What is the stock symbol of Corteva? | Corteva trades under CTVA ticker. |
| When did Corteva go public? | Corteva went public in 2019. |
| Who are competitors of Corteva? | Corteva main competitors include BASF, Archer-Daniels-Midland, Archer-Daniels-Midland, Nutrien, Novonesis, Bunge, Qinghai Salt Lake Industry, Industries Qatar, Wilmar International. |
| What is the current market cap of Corteva? | Corteva's current market cap is $52B. |
| What is the current revenue of Corteva? | Corteva's last 12 months revenue is $18B. |
| What is the current revenue growth of Corteva? | Corteva revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Corteva? | Current revenue multiple of Corteva is 3.0x. |
| What is the current EBITDA of Corteva? | Corteva's last 12 months EBITDA is $4B. |
| What is Corteva's EBITDA margin? | Corteva's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Corteva? | Current EBITDA multiple of Corteva is 13.4x. |
| What is the current FCF of Corteva? | Corteva's last 12 months FCF is $2B. |
| What is Corteva's FCF margin? | Corteva's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Corteva? | Current FCF multiple of Corteva is 26.6x. |
| How many companies Corteva has acquired to date? | As of June 2026, Corteva has acquired 2 companies. |
| What was the largest acquisition by Corteva? | $1B acquisition of The Stoller Group on 30th November 2022 was the largest M&A Corteva has done to date. |
| What companies Corteva acquired? | Corteva acquired The Stoller Group and Symborg. |
| In how many companies Corteva has invested to date? | As of June 2026, Corteva has invested in 4 companies. |
See public comps similar to Corteva
Lists including Corteva
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




